Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy?
Hypertrophic obstructive cardiomyopathy is an inheritable cardiac disease that typically manifests with an increased left ventricular outflow tract gradient. In most cases, basal septal hypertrophy and systolic anterior motion of the anterior mitral valve leaflet are the key components of the left v...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KARE Publishing
2018-05-01
|
| Series: | Türk Kardiyoloji Derneği Arşivi |
| Subjects: | |
| Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-49383 |
| _version_ | 1797911975365181440 |
|---|---|
| author | Elnur Alizade Sabahattin Gündüz Ahmet Güner Khagani Isgandarov Selçuk Pala |
| author_facet | Elnur Alizade Sabahattin Gündüz Ahmet Güner Khagani Isgandarov Selçuk Pala |
| author_sort | Elnur Alizade |
| collection | DOAJ |
| description | Hypertrophic obstructive cardiomyopathy is an inheritable cardiac disease that typically manifests with an increased left ventricular outflow tract gradient. In most cases, basal septal hypertrophy and systolic anterior motion of the anterior mitral valve leaflet are the key components of the left ventricular outflow tract obstruction. The goal of septal reduction therapy, a widely accepted treatment modality, is to remove this obstruction. Although myectomy is a well-established and effective surgical technique for septal reduction therapy, transcoronary alcohol septal ablation is an alternative therapy for patients who decline to have surgery or who are not suited to a surgical intervention. A new septal reduction method has also been described in the literature. This case report describes the successful treatment of hypertrophic obstructive cardiomyopathy in a 57-year-old female using the new septal reduction technique. |
| first_indexed | 2024-04-10T11:50:11Z |
| format | Article |
| id | doaj.art-199619ab55314cbaa8d1904b2b321535 |
| institution | Directory Open Access Journal |
| issn | 1016-5169 |
| language | English |
| last_indexed | 2024-04-10T11:50:11Z |
| publishDate | 2018-05-01 |
| publisher | KARE Publishing |
| record_format | Article |
| series | Türk Kardiyoloji Derneği Arşivi |
| spelling | doaj.art-199619ab55314cbaa8d1904b2b3215352023-02-15T16:17:10ZengKARE PublishingTürk Kardiyoloji Derneği Arşivi1016-51692018-05-0146429630010.5543/tkda.2018.49383TKDA-49383Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy?Elnur Alizade0Sabahattin Gündüz1Ahmet Güner2Khagani Isgandarov3Selçuk Pala4Department of Cardiology, Kartal Koşuyolu Heart Training and Research Hospital, İstanbul, TurkeyDepartment of Cardiology, Kartal Koşuyolu Heart Training and Research Hospital, İstanbul, TurkeyDepartment of Cardiology, Kartal Koşuyolu Heart Training and Research Hospital, İstanbul, TurkeyDepartment of Cardiology, Kartal Koşuyolu Heart Training and Research Hospital, İstanbul, TurkeyDepartment of Cardiology, Kartal Koşuyolu Heart Training and Research Hospital, İstanbul, TurkeyHypertrophic obstructive cardiomyopathy is an inheritable cardiac disease that typically manifests with an increased left ventricular outflow tract gradient. In most cases, basal septal hypertrophy and systolic anterior motion of the anterior mitral valve leaflet are the key components of the left ventricular outflow tract obstruction. The goal of septal reduction therapy, a widely accepted treatment modality, is to remove this obstruction. Although myectomy is a well-established and effective surgical technique for septal reduction therapy, transcoronary alcohol septal ablation is an alternative therapy for patients who decline to have surgery or who are not suited to a surgical intervention. A new septal reduction method has also been described in the literature. This case report describes the successful treatment of hypertrophic obstructive cardiomyopathy in a 57-year-old female using the new septal reduction technique.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-49383alcohol septal ablationhypertrophic cardiomyopathy; myectomy. |
| spellingShingle | Elnur Alizade Sabahattin Gündüz Ahmet Güner Khagani Isgandarov Selçuk Pala Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy? Türk Kardiyoloji Derneği Arşivi alcohol septal ablation hypertrophic cardiomyopathy; myectomy. |
| title | Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy? |
| title_full | Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy? |
| title_fullStr | Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy? |
| title_full_unstemmed | Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy? |
| title_short | Is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy? |
| title_sort | is subcutaneous fat tissue embolization effective and safe as a septal reduction technique in a patient with hypertrophic obstructive cardiomyopathy |
| topic | alcohol septal ablation hypertrophic cardiomyopathy; myectomy. |
| url | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-49383 |
| work_keys_str_mv | AT elnuralizade issubcutaneousfattissueembolizationeffectiveandsafeasaseptalreductiontechniqueinapatientwithhypertrophicobstructivecardiomyopathy AT sabahattingunduz issubcutaneousfattissueembolizationeffectiveandsafeasaseptalreductiontechniqueinapatientwithhypertrophicobstructivecardiomyopathy AT ahmetguner issubcutaneousfattissueembolizationeffectiveandsafeasaseptalreductiontechniqueinapatientwithhypertrophicobstructivecardiomyopathy AT khaganiisgandarov issubcutaneousfattissueembolizationeffectiveandsafeasaseptalreductiontechniqueinapatientwithhypertrophicobstructivecardiomyopathy AT selcukpala issubcutaneousfattissueembolizationeffectiveandsafeasaseptalreductiontechniqueinapatientwithhypertrophicobstructivecardiomyopathy |